Turk Ilac ve SerumnayiIST:TRILC -2.48%61 Days Payable is 48.39 as of Sep. 2025, which is 32% above its 10-year median of 36.78. GuruFocus rates IST:TRILC with a GF Score™ of 61/100 and a GF Value™ of ₺3.60 (Possible Value Trap). The stock has 11 warning signs investors should review. Among 922 Drug Manufacturers companies, Turk Ilac ve Serumnayi ranks worse than 77.01% on this metric.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
IST:TRILC vs ZTS, UTHR, VTRS: Days Payable Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Turk Ilac ve Serumnayi's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Turk Ilac ve Serumnayi Days Payable vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Turk Ilac ve Serumnayi's Days Payable distribution charts can be found below:
* The bar in red indicates where Turk Ilac ve Serumnayi's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
Turk Ilac ve Serumnayi's Days Payable for the fiscal year that ended in Dec. 2024 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Turk Ilac ve Serumnayi (IST:TRILC) has a Days Payable of 48.39 as of Sep. 2025. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Turk Ilac ve Serumnayi and its competitors. This is 32% above median its historical median of 36.78. Over the past decade, Turk Ilac ve Serumnayi's Days Payable has ranged from 23.82 to 298.30. According to the industry distribution chart, Turk Ilac ve Serumnayi ranks #710 out of 922 companies in the Drug Manufacturers industry, placing it in the top 77%.
Is Turk Ilac ve Serumnayi's Days Payable too high?
Turk Ilac ve Serumnayi's current Days Payable of 48.39 is 32% above median its 10-year median of 36.78. Over the past 10 years, this metric has ranged from a low of 23.82 to a high of 298.30. The Drug Manufacturers industry median Days Payable is 90.84. Turk Ilac ve Serumnayi's value of 48.39 is 46.7% below this industry median. Based on the distribution chart, Turk Ilac ve Serumnayi ranks #710 out of 922 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, Turk Ilac ve Serumnayi has a GF Score™ of 61/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Turk Ilac ve Serumnayi's Days Payable compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Turk Ilac ve Serumnayi ranks #710 out of 922 companies for Days Payable. This places Turk Ilac ve Serumnayi in the lower half of its industry. The industry median Days Payable is 90.84. Turk Ilac ve Serumnayi's value of 48.39 is 46.7% below this benchmark. Historically, Turk Ilac ve Serumnayi's own Days Payable has ranged from 23.82 to 298.30 over the past decade. While the company's 10-year median is 36.78 vs. the industry median of 90.84, Turk Ilac ve Serumnayi has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Drug Manufacturers company?
The median Days Payable among Drug Manufacturers companies is 90.84, based on 922 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Turk Ilac ve Serumnayi's current Days Payable of 48.39 is 46.7% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Turk Ilac ve Serumnayi and its competitors. For the Drug Manufacturers industry, the median Days Payable is 90.84 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Turk Ilac ve Serumnayi's current Days Payable is 48.39, which is 32% above median its own 10-year median of 36.78. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Turk Ilac ve Serumnayi stock overvalued right now?
Based on GuruFocus' analysis, Turk Ilac ve Serumnayi (IST:TRILC) is currently considered Possible Value Trap. The stock's GF Value™ is ₺3.60, compared to a current price of ₺1.18 — trading 67.2% below its estimated fair value. The current Days Payable is 48.39, which is 32% above median its 10-year median of 36.78 and 46.7% below the Drug Manufacturers industry median of 90.84. Turk Ilac ve Serumnayi's overall GF Score™ is 61/100 with 11 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Turk Ilac ve Serumnayi (IST:TRILC), the current Days Payable is 48.39 as of Sep. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Turk Ilac ve Serumnayi (IST:TRILC) Overvalued in 2026?
Based on GuruFocus' analysis, Turk Ilac ve Serumnayi stock appears to be undervalued.
The current stock price of ₺1.18 is trading 67.2% below its estimated GF Value™ of ₺3.60.
GuruFocus considers Turk Ilac ve Serumnayi to be Possible Value Trap.
Key valuation signals for IST:TRILC:
Days Payable: 48.39 (32% above median its 10-year median of 36.78)
GF Value™: ₺3.60 vs. price of ₺1.18 (67.2% below fair value)
Industry Position: 46.7% below the Drug Manufacturers median (#710 of 922)
No single metric tells the full story. See the IST:TRILC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
IST:TRILC has been successfully added to your 
